CN111568846A - 一种抗痤疮制剂 - Google Patents
一种抗痤疮制剂 Download PDFInfo
- Publication number
- CN111568846A CN111568846A CN202010649441.XA CN202010649441A CN111568846A CN 111568846 A CN111568846 A CN 111568846A CN 202010649441 A CN202010649441 A CN 202010649441A CN 111568846 A CN111568846 A CN 111568846A
- Authority
- CN
- China
- Prior art keywords
- skin
- acne
- prebiotics
- oligosaccharide
- sebum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公布了一种抗痤疮制剂,包含以下质量百分比的各组分:油溶性毛喉鞘蕊提取物1~5%,皮脂抑制剂1~10%,益生元0.5~5%,皮肤屏障功能修复剂0.5~5%,皮肤调理剂0.5~5%,润肤剂10~20%,增稠剂0.1~0.5%,防腐剂0.1~1%,水余量。本发明将毛喉鞘蕊提取物作为抗菌剂,有效抑制痤疮丙酸杆菌、金黄色葡萄球菌、表皮葡萄球菌等皮肤病原体大量繁殖;以聚季铵盐‑22和烟酰胺作为皮脂抑制剂,减少皮脂分泌和痤疮的扩散范围;通过益生元选择性地促进有益菌的代谢和增殖,平衡皮肤的微生物群;植物甾醇酯作为皮肤屏障功能修复剂,促进痤疮快速收口,修复痤疮皮损,缓解炎症反应,温和无刺激。
Description
技术领域
本发明属于皮肤护理技术领域,特别是涉及一种抗痤疮制剂。
背景技术
痤疮是一种皮肤无法正常排泄油脂而引发的一连串炎症反应,是毛囊皮脂腺组织的慢性炎症性皮肤症状,主要发于颜面、胸背等皮脂分泌旺盛部位,临床表现为粉刺、炎性丘疹、脓包、结节、囊肿等多形性皮损。痤疮的发病机制较为复杂,主要与皮脂分泌增加、毛囊皮脂腺导管化异常、微生物在毛囊皮脂腺内定植、内分泌等有关。
毛囊皮脂腺中的微生物在痤疮发病过程中起重要作用,丙酸杆菌是毛囊皮脂腺内数量最多的微生物,与痤疮的发病密切相关。其中,痤疮丙酸杆菌的作用最为关键,是痤疮患者毛囊皮脂腺内优势菌群,占所有检测到微生物数量的89%。除了痤疮丙酸杆菌以外,还包括金黄色葡萄球菌、表皮葡萄球菌、马拉色菌等。表皮葡萄球菌是一种凝固酶阴性的革兰氏阳性菌,在痤疮患者毛囊皮脂腺内定植的微生物中占6.8~47.3%,仅次于痤疮丙酸杆菌。
痤疮的治疗目前多以药物治疗为主,局部治疗中以维A酸类药物与抗菌药物联用,如全反式维A酸、阿达帕林与他扎罗汀治疗轻度痤疮;口服治疗药物中维A酸类药物主要用于重度痤疮,口服抗菌药物适用于中、重度痤疮患者,但都存在潜在安全问题,需严格控制使用剂量,因此,开发一种无耐药性、具有皮肤屏障修护功能的抗痤疮制剂具有重要意义。
发明内容
本发明的目的是为了克服现有技术中存在的不足,提供一种具有皮肤屏障修护功能,可以缓解炎症反应,调节毛囊皮脂腺微生态,温和无刺激的抗痤疮制剂。
本发明为实现上述目的,采用如下技术方案:
一种抗痤疮制剂,其特征在于,包含以下质量百分比的各组分:油溶性毛喉鞘蕊提取物1~5%,皮脂抑制剂1~10%,益生元0.5~5%,皮肤屏障功能修复剂0.5~5%,皮肤调理剂0.5~5%,润肤剂10~20%,增稠剂0.1~0.5%,防腐剂0.1~1%,水余量。
毛喉鞘蕊系唇形科鞘蕊花属植物,具有强心、降压、平喘、抗血栓及降低眼内压等药理作用,现临床上开始用于心脑血管病、肿瘤和老年常患疾病等的治疗。毛喉鞘蕊提取物中含有α-雪松醇、福司可林、美迪紫檀素、β-谷甾醇、愈创木酚甘油醚、齐墩果酸、2-呋喃甲酸、乙酸龙脑酯等成分,具有抗菌、消炎、镇静等生物学益处,能有效抑制痤疮丙酸杆菌、金黄色葡萄球菌、表皮葡萄球菌等皮肤病原体大量繁殖,修复肌肤受损组织,可以预防或缓解痤疮症状。
其进一步特征在于:所述皮脂抑制剂为聚季铵盐-22和烟酰胺。
聚季铵盐-22可以使皮肤变得更亲脂,减小皮肤的表面张力,从而使分泌出来的皮脂在皮肤表面的扩散速度明显减慢,虽然没有直接减少皮脂的量,但可以减少痤疮的扩散范围。
烟酰胺可以抑制皮脂腺细胞以葡萄糖为底物合成脂质的反应,特异性抑制脂肪酸和三酰甘油合成,减少皮脂分泌,防止毛囊阻塞,避免痤疮丙酸杆菌大量繁殖。同时,其化学结构上含有吡啶环,对痤疮丙酸杆菌及皮脂产物刺激引起的白细胞趋化活性有抑制作用,可有效治疗痤疮。
进一步的:所述益生元为菊粉、α-葡聚糖寡糖、低聚果糖、低聚异麦芽糖、低聚半乳糖、低聚木糖中的至少一种。
益生元是不被宿主消化吸收、选择性促进一种或多种益生菌代谢和增殖的有机物质。益生菌群的生长对人体皮肤具有多重作用,首先,益生菌会参与皮肤皮脂腺代谢,形成一层乳化脂质膜,这层脂质膜由游离脂肪酸构成,它可以中和沾染皮肤上的碱性物质,抑制暂住菌、真菌等致病微生物的定植、生长和繁殖,对皮肤自净起重要作用。其次,有层次并且有序地定植在皮肤上的益生菌群,尤如一层生物膜,不仅对机体裸露的表皮起了占位保护作用,而且与其他菌群彼此相互依赖、相互制约,形成一个相互稳定相互和谐的生物屏障,提高皮肤免疫功能,保护机体的健康。第三,皮肤表面的益生菌生长会分解产生磷脂、固醇类、角质蛋白等成分,可以被皮肤细胞吸收,促进皮肤细胞生长,延缓老化和减少皱纹产生。
当皮肤环境微生态改变时,有害菌会大量繁殖并取代益生菌的位置,使益生菌数量减少,菌群失调,皮肤的第一道屏障被破坏,皮肤会出现红肿、炎症等症状。益生元不被有害菌利用,能够选择性地促进有益菌的代谢和增殖,强化益生菌群,与杀菌剂同时使用时,对益生菌起到竞争性保护作用,形成皮肤保护屏障,阻止有害菌的入侵,减少痤疮再次出现的几率。此外,在重新平衡皮肤的微生物群时,还能提供良好的皮肤保湿功效。
所述皮肤屏障功能修复剂为大豆甾醇乙酸酯、植物甾醇澳洲坚果油酸酯、植物甾醇油酸酯中的至少一种植物甾醇酯。
大豆甾醇乙酸酯、植物甾醇澳洲坚果油酸酯、植物甾醇油酸酯都是植物甾醇酯,由植物甾醇酯化改性所得,具有良好的油溶性和较强的渗透性、抗氧化性、抗炎性,能到达真表皮连接层,维持细胞的柔软和湿润,保持皮肤表面水份,促进皮肤新陈代谢,改善肌肤的结构和功能,促进痤疮快速收口,修复痤疮的皮损,进而防止瘢痕产生。
所述皮肤调理剂为红没药醇、燕麦仁提取物、玉米须丝提取物、尿囊素等成分。
所述润肤剂为霍霍巴籽油、野大豆油、PPG-3肉豆蔻醇醚、丁二醇等。
所述增稠剂为紫虫胶、黄原胶等。
上述的抗痤疮制剂可用于制备治疗痤疮的膜剂、软膏剂、粉剂等产品中。
与现有技术相比,本发明的优点在于:本发明将毛喉鞘蕊提取物作为抗菌剂,有效抑制痤疮丙酸杆菌、金黄色葡萄球菌、表皮葡萄球菌等皮肤病原体大量繁殖;以聚季铵盐-22和烟酰胺作为皮脂抑制剂,减少皮脂分泌和痤疮的扩散范围;通过益生元选择性地促进有益菌的代谢和增殖,平衡皮肤的微生物群;植物甾醇酯作为皮肤屏障功能修复剂,促进痤疮快速收口,修复痤疮皮损,缓解炎症反应,温和无刺激。
附图说明
图1为本发明高效消毒剂抑菌效果示意图。
其中图1(a)为水溶性毛喉鞘蕊提取物对表皮葡萄球菌的抑菌效果,图1(b)为油溶性毛喉鞘蕊提取物对表皮葡萄球菌的抑菌效果,图1(c)为水溶性毛喉鞘蕊提取物对痤疮丙酸杆菌的抑菌效果,图1(d)为油溶性毛喉鞘蕊提取物对痤疮丙酸杆菌的抑菌效果。1~6分别为实施例1~6。
具体实施方式
以下结合实施例对本发明作进一步详细描述,所述实施例只用于解释本发明,并非用于限定本发明的范围。下述实施例中所用的试验方法如无特殊说明,均为常规方法;所用的材料、试剂等,如无特殊说明,为可从商业途径得到的试剂和材料。以下各组分为含量为质量百分比。
实施例1
实施例2
实施例3
实施例4
实施例5
实施例6
1、采用本发明所制备的抗痤疮制剂抑菌效果评价:
将表皮葡萄球菌CMCC 26069、痤疮丙酸杆菌ATCC 6919进行活化,取4~8代新鲜斜面培养物,用pH7.2的PBS将菌苔洗下,用紫外分光光度计调节,使菌悬液OD600=0.5。取100μL10倍稀释的菌悬液涂布琼脂平板,干燥后等间距放上药敏试纸,滴加10μL实施例1~6中配制的抗痤疮制剂,37℃培养24~48h,观察抑菌效果,见图1。
从图1(a)(c)中可以看出,实施例1~3对表皮葡萄球菌、痤疮丙酸杆菌无明显抑菌效果。从图1(b)(d)中可以看出,实施例4~6对表皮葡萄球菌、痤疮丙酸杆菌均有明显的抑菌效果。当抗痤疮制剂中油溶性毛喉鞘蕊提取物含量大于1%时,对表皮葡萄球菌、痤疮丙酸杆菌有显著的抑菌效果,并且随着油溶性毛喉鞘蕊提取物含量增加,抑菌效果也增强。
2、竞争性生长测试
将菌悬液OD600=0.5的嗜酸乳杆菌、表皮葡萄球菌/金黄色葡萄球菌,按10%接种量接种至含1%益生元(菊粉和α-葡聚糖寡糖)的胰蛋白胨大豆肉汤中,37℃培养24h,然后进行平板计数,评价益生元在益生菌(嗜酸乳杆菌)与病原菌(表皮葡萄球菌/金黄色葡萄球菌)同时存在时对菌群生长的影响,见表1。从表中可以看出,益生元能促进益生菌的生长,但对病原菌无促进作用。
表1竞争性生长结果
Claims (4)
1.一种抗痤疮制剂,其特征在于,包含以下质量百分比的各组分:油溶性毛喉鞘蕊提取物1~5%,皮脂抑制剂1~10%,益生元0.5~5%,皮肤屏障功能修复剂0.5~5%,皮肤调理剂0.5~5%,润肤剂10~20%,增稠剂0.1~0.5%,防腐剂0.1~1%,水余量。
2.如权利要求1所述的抗痤疮制剂,其特征在于:所述皮脂抑制剂为聚季铵盐-22和烟酰胺。
3.如权利要求1或2所述的抗痤疮制剂,其特征在于:所述益生元为菊粉、α-葡聚糖寡糖、低聚果糖、低聚异麦芽糖、低聚半乳糖、低聚木糖中的至少一种。
4.如权利要求1或2所述的抗痤疮制剂,其特征在于:所述皮肤屏障功能修复剂为大豆甾醇乙酸酯、植物甾醇澳洲坚果油酸酯、植物甾醇油酸酯中的至少一种植物甾醇酯。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010649441.XA CN111568846A (zh) | 2020-07-08 | 2020-07-08 | 一种抗痤疮制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010649441.XA CN111568846A (zh) | 2020-07-08 | 2020-07-08 | 一种抗痤疮制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111568846A true CN111568846A (zh) | 2020-08-25 |
Family
ID=72110148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010649441.XA Pending CN111568846A (zh) | 2020-07-08 | 2020-07-08 | 一种抗痤疮制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111568846A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113493487A (zh) * | 2021-04-29 | 2021-10-12 | 深圳海创生物科技有限公司 | 一种化合物和组合物及其在制备促进益生菌增殖和/或抑制有害菌生长的产品中的应用 |
CN113576943A (zh) * | 2021-07-09 | 2021-11-02 | 中山大学 | 一种益生元发酵物及其制备方法与应用 |
EP3973971A1 (de) * | 2020-09-28 | 2022-03-30 | Medice Arzneimittel Pütter GmbH & Co. KG | Probiotische pharmazeutische zusammensetzung |
CN115969752A (zh) * | 2023-01-19 | 2023-04-18 | 广州环亚化妆品科技股份有限公司 | 无患子发酵物在调节皮肤微生态平衡中的应用 |
CN117860649A (zh) * | 2024-03-08 | 2024-04-12 | 珠海金肽生物科技有限公司 | 一种调节皮肤微生态和修复肌肤屏障的组合物及应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020160066A1 (en) * | 2001-02-20 | 2002-10-31 | Muhammed Majeed | Composition and methods containing an antimicrobial essential oil extracted from Coleus forskohlii |
CN107412045A (zh) * | 2017-05-19 | 2017-12-01 | 广州蜜妆生物科技有限公司 | 一种益生元健肤面膜 |
CN111374896A (zh) * | 2018-12-28 | 2020-07-07 | 西安臻瑞生物科技有限公司 | 一种治疗痤疮的益生元和益生菌护肤品及其制备方法 |
-
2020
- 2020-07-08 CN CN202010649441.XA patent/CN111568846A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020160066A1 (en) * | 2001-02-20 | 2002-10-31 | Muhammed Majeed | Composition and methods containing an antimicrobial essential oil extracted from Coleus forskohlii |
CN107412045A (zh) * | 2017-05-19 | 2017-12-01 | 广州蜜妆生物科技有限公司 | 一种益生元健肤面膜 |
CN111374896A (zh) * | 2018-12-28 | 2020-07-07 | 西安臻瑞生物科技有限公司 | 一种治疗痤疮的益生元和益生菌护肤品及其制备方法 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3973971A1 (de) * | 2020-09-28 | 2022-03-30 | Medice Arzneimittel Pütter GmbH & Co. KG | Probiotische pharmazeutische zusammensetzung |
CN113493487A (zh) * | 2021-04-29 | 2021-10-12 | 深圳海创生物科技有限公司 | 一种化合物和组合物及其在制备促进益生菌增殖和/或抑制有害菌生长的产品中的应用 |
CN113493487B (zh) * | 2021-04-29 | 2022-05-17 | 深圳海创生物科技有限公司 | 一种化合物和组合物及其在制备促进益生菌增殖和/或抑制有害菌生长的产品中的应用 |
CN113576943A (zh) * | 2021-07-09 | 2021-11-02 | 中山大学 | 一种益生元发酵物及其制备方法与应用 |
CN115969752A (zh) * | 2023-01-19 | 2023-04-18 | 广州环亚化妆品科技股份有限公司 | 无患子发酵物在调节皮肤微生态平衡中的应用 |
CN115969752B (zh) * | 2023-01-19 | 2024-03-01 | 广州环亚化妆品科技股份有限公司 | 无患子发酵物在调节皮肤微生态平衡中的应用 |
CN117860649A (zh) * | 2024-03-08 | 2024-04-12 | 珠海金肽生物科技有限公司 | 一种调节皮肤微生态和修复肌肤屏障的组合物及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111568846A (zh) | 一种抗痤疮制剂 | |
US10449222B2 (en) | Method for preventing and/or treating infections, colonisations, or illnesses related to Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pyogenes, Enterococcus faecium, Enterobacter cloacae, Proteus mirabilis, Bacteroides fragilis, Staphylococcus epidermidis, Propionibacterium acnes, Candida albicans and/or Malassezia furfur | |
EP2836223B1 (en) | Method of repairing skin using Lactobacillus rhamnosus GG | |
JP4678896B2 (ja) | 微生物感染を予防または制御するための共生Bacillus芽胞の局所的使用 | |
USRE46718E1 (en) | Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains | |
Cinque et al. | Use of probiotics for dermal applications | |
US11666586B2 (en) | Compositions and methods for treating acne vulgaris | |
Fei et al. | Role of prebiotics in enhancing the function of next-generation probiotics in gut microbiota | |
EP3813859A1 (en) | Lactobacillus plantarum for skin care | |
Peng et al. | Polyphenols and tri-terpenoids from Olea europaea L. in alleviation of enteric pathogen infections through limiting bacterial virulence and attenuating inflammation | |
KR20070079497A (ko) | 생약성분 추출물을 함유하는 피부 외용제 조성물 | |
TWI750716B (zh) | 皮膚外用組成物及其用於製備改善皮膚疾病及皮膚發炎之組成物的用途 | |
WO2005030230A1 (en) | Compositions and methods for treatment or prevention of psoriasis and related disorders | |
JP2018509464A (ja) | 抗菌組成物 | |
CN111374896A (zh) | 一种治疗痤疮的益生元和益生菌护肤品及其制备方法 | |
CN109475584B (zh) | 治疗由阴道加德纳氏菌导致的细菌性阴道感染和可能存在的并发真菌感染的乳酸菌组合物 | |
Katsunuma et al. | Effect of Yucca shidigera extract and saponins on growth of bacteria isolated from animal intestinal tract | |
CN110075270A (zh) | 抑制幽门螺杆菌的乳酸链球菌素肠溶片及其制备方法 | |
Muhsinin et al. | Formulation and Evaluation of a Turmeric Kombucha Facial Toner with Potential as an Anti-Acne Agent | |
US20230218666A1 (en) | Antimicrobial combinations | |
US20230115784A1 (en) | Compositions and methods for treating acne vulgaris | |
KR102545060B1 (ko) | 천연소재 발효추출물을 유효성분으로 함유하는 여드름 개선용 화장료 조성물 | |
CN114053318A (zh) | 菌群调节用组合物 | |
KR101940053B1 (ko) | 포제 추출물을 포함하는 조성물 | |
CN118252900A (zh) | 一种改善口腔细菌群的中药益生菌组合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200825 |